Applied Therapeutics, Inc. Common Stock logo

APLT Q3 2025 Earnings Results — Applied Therapeutics, Inc. Common Stock

XNAS · Healthcare · Biotechnology

Updated

Price $0.10
Market Cap $162.7M
P/E —
52W Range $0.09 – $1.50

When is APLT's next earnings date?

Applied Therapeutics, Inc. Common Stock (APLT) has not announced its next earnings date yet. Its most recent earnings report was on Thursday, November 13, 2025.

How did APLT do in its last earnings report?

In its most recent report on Nov 13, 2025 (Q3 2025), Applied Therapeutics, Inc. Common Stock posted EPS of -$0.13 versus the -$0.14 estimate, a beat of 7.1%. Revenue was $1.0M against a $250,000 estimate. The stock's 1-day post-earnings move was -70.3%.

How much does APLT stock move after earnings?

APLT beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 11.7% (up or down) in the day after earnings.

About Applied Therapeutics, Inc. Common Stock

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2025-11-13Q3 2025-0.14-0.13+7.14%$1.0M✅ Beat-70.33%-68.68%-87.11%
2025-08-13Q2 2025-0.16-0.15+6.25%$0✅ Beat+4.54%+10.61%-6.84%
2025-04-14Q4 2024-0.180.33+283.33%$0✅ Beat-11.06%-6.78%+31.49%
2024-11-07Q3 2024-0.16-0.48-200.00%$122,000❌ Miss+0.93%-7.56%-86.74%
2024-08-07Q2 2024-0.16-0.13+18.75%$144,000✅ Beat+1.64%+0.82%-4.26%
2024-03-06Q4 2023-0.23-0.40-73.91%$-667,000❌ Miss+4.70%-2.59%-4.05%
2023-08-10Q2 2023-0.26-0.37-42.31%$0❌ Miss+0.64%-17.95%+1.28%
2023-05-11Q1 2023-0.31-0.18+41.94%$10.7M✅ Beat+0.00%-7.88%-10.91%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .